Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

HME Insider Trading

HME | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at HME provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2005-05-05 18:35 2005-05-03 SMITH JOHN E Officer - Senior Vice President OPT+S $41.33 768 $31,741 15,762 0.0%
2005-05-05 18:31 2005-05-03 LEENHOUTS NORMAN P Director SELL $41.52 24,043 $998,309 6,500 -78.7%
2005-05-05 18:37 2005-05-04 LEENHOUTS NELSON B Director SELL $41.56 18,500 $768,893 6,500 -74.0%
2005-04-06 22:12 2005-03-31 KOBER ROGER W Director SELL $39.11 5,747 $224,755 14,929 -27.8%
2005-04-05 18:46 2005-04-01 TAIT AMY L Director SELL $39.49 300 $11,847 15,855 -1.9%
2005-04-05 21:11 2005-04-04 PETTINELLA EDWARD J Director, Officer - CEO and President BUY $38.61 15,000 $579,078 153,204 +10.9%
2005-04-04 22:32 2005-04-01 HELBIG LEONARD F III Director OPT+S $38.77 1,980 $76,765 41,049 0.0%
2005-04-04 17:29 2005-03-31 TAIT AMY L Director SELL $39.49 4,500 $177,705 16,155 -21.8%
2005-03-16 23:57 2005-03-14 GOSULE ALAN L Director OPT+S $40.26 2,700 $108,708 4,229 0.0%
2004-12-06 22:20 2004-12-03 TAIT AMY L Director OPT+S $42.26 5,000 $211,302 67,887 0.0%
2004-12-02 23:01 2004-12-01 LEENHOUTS NORMAN P Director SELL $41.50 2,400 $99,600 94,056 -2.5%
2004-11-29 23:20 2004-11-24 LEENHOUTS NORMAN P Director SELL $41.54 7,100 $294,902 96,456 -6.9%
2004-11-18 23:33 2004-11-16 LEENHOUTS NORMAN P Director SELL $42.75 10,500 $448,866 105,566 -9.0%
2004-11-18 23:35 2004-11-16 LEENHOUTS NELSON B Director OPT+S $42.99 20,000 $859,800 82,971 0.0%
2004-11-17 19:43 2004-11-15 TAIT AMY L Director OPT+S $43.15 7,000 $302,050 67,887 0.0%
2004-11-12 19:58 2004-11-10 TAIT AMY L Director OPT+S $41.99 7,000 $293,930 67,887 0.0%
2004-11-12 19:57 2004-11-09 LEENHOUTS NORMAN P Director OPT+S $41.98 78,487 $3,294,767 116,066 0.0%
2004-11-12 19:58 2004-11-10 LEENHOUTS NELSON B Director OPT+S $42.04 28,487 $1,197,727 82,971 0.0%
2004-09-02 22:27 2004-08-31 LEENHOUTS NORMAN P Director OPT+S $40.33 42,686 $1,721,526 133,053 0.0%
2004-09-02 22:28 2004-09-02 LEENHOUTS NELSON B Director OPT+S $40.18 6,314 $253,701 95,958 0.0%
2004-08-31 22:07 2004-08-30 LEENHOUTS NORMAN P Director OPT+S $39.99 15,000 $599,856 133,053 0.0%
2004-08-11 22:32 2004-08-11 LEENHOUTS NORMAN P Director OPT+S $38.45 1,000 $38,449 6,369 0.0%
2004-05-24 21:38 2004-05-21 LEENHOUTS NELSON B Director SELL $37.72 9,000 $339,477 95,958 -8.6%
2004-04-08 18:11 2004-04-07 GOSULE ALAN L Director OPT+S $39.90 3,500 $139,650 3,991 0.0%
2004-03-05 00:49 2004-03-04 LEENHOUTS NELSON B Director SELL $41.44 5,000 $207,200 103,588 -4.6%
2004-03-04 01:11 2004-03-02 LEENHOUTS NORMAN P Director SELL $41.02 26,938 $1,104,954 0 -100.0%
2004-03-04 01:09 2004-03-02 LEENHOUTS NELSON B Director SELL $41.09 16,938 $695,955 0 -100.0%
2004-03-03 23:38 2004-03-02 DOYLE SCOTT Officer - Senior Vice President SELL $40.75 1,663 $67,767 157 -91.4%
2004-02-27 00:13 2004-02-25 LEENHOUTS NORMAN P Director SELL $40.00 15,250 $610,052 16,938 -47.4%
2004-02-27 00:14 2004-02-25 LEENHOUTS NELSON B Director SELL $40.00 15,250 $610,052 16,938 -47.4%
2004-02-25 22:47 2004-02-23 KOBER ROGER W Director SELL $39.43 3,363 $132,589 12,952 -20.6%
2004-02-25 23:07 2004-02-23 LEENHOUTS NORMAN P Director SELL $39.86 7,500 $298,980 32,188 -18.9%
2004-02-25 23:08 2004-02-23 LEENHOUTS NELSON B Director SELL $39.86 7,500 $298,980 32,188 -18.9%
2004-02-24 23:23 2004-02-23 BALDERSTON WILLIAM III Director SELL $39.75 2,900 $115,275 15,149 -16.1%
2004-02-20 22:34 2004-02-19 KOBER ROGER W Director OPT+S $40.00 3,500 $140,000 16,315 0.0%
2004-02-20 22:35 2004-02-19 LEENHOUTS NORMAN P Director SELL $40.00 5,000 $200,000 145,997 -3.3%
2004-02-13 20:05 2004-02-11 TAIT AMY L Director OPT+S $40.70 2,600 $105,820 9,771 0.0%
2004-02-13 22:06 2004-02-11 LEENHOUTS NELSON B Director OPT+S $40.72 87,840 $3,576,669 108,588 0.0%
2003-12-30 21:05 2003-12-24 AUGUST BURTON S Director BUY $40.35 9,100 $367,161 9,375 +3,309.1%
2003-12-30 21:05 2003-12-24 AUGUST BURTON S Director SELL $40.16 9,100 $365,428 275 -97.1%
2003-12-17 18:47 2003-12-15 TAIT AMY L Director OPT+S $40.99 4,100 $168,059 67,487 0.0%
2003-12-11 22:40 2003-12-09 TAIT AMY L Director OPT+S $40.99 900 $36,891 67,487 0.0%
2003-12-01 23:58 2003-11-28 TAIT AMY L Director OPT+S $40.24 10,000 $402,400 67,487 0.0%
2003-11-26 22:39 2003-11-26 TAIT AMY L Director OPT+S $39.49 5,000 $197,450 67,487 0.0%
2003-11-26 19:03 2003-11-25 LEENHOUTS NORMAN P Director, Officer - Chairman and Co-CEO SELL $39.45 5,000 $197,250 142,831 -3.4%
2003-11-26 19:02 2003-11-26 LEENHOUTS NELSON B Director, Officer - President & Co-CEO SELL $39.57 5,000 $197,850 106,422 -4.5%
2003-11-19 23:49 2003-11-18 LEENHOUTS NORMAN P Director, Officer - Chairman and Co-CEO SELL $39.59 4,900 $193,991 147,831 -3.2%
2003-11-17 23:45 2003-11-14 LEENHOUTS NORMAN P Director, Officer - Chairman and Co-CEO SELL $39.59 100 $3,959 152,731 -0.1%
2003-11-13 21:54 2003-11-12 LEENHOUTS NORMAN P Director, Officer - Chairman and Co-CEO SELL $39.24 5,000 $196,200 152,831 -3.2%
2003-11-13 21:53 2003-11-12 LEENHOUTS NELSON B Director, Officer - President and Co-CEO SELL $39.25 5,000 $196,272 101,794 -4.7%
SHOW ENTRIES

How to Interpret $HME Trades

Not every insider transaction in HME is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HME shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for HME

Insider activity data for HME is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HME, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.